[{"Assets_0_Q1_USD":52409000.0,"CommonStockSharesOutstanding_0_Q1_shares":36502000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":405000.0,"NetIncomeLoss_1_Q1_USD":-7659000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":18027000.0,"StockholdersEquity_0_Q1_USD":20935000.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180508"}]